+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Near Patient Care Diagnostic Market - Global Forecast 2026-2032- Product Image
Near Patient Care Diagnostic Market - Global Forecast 2026-2032- Product Image
Sale

Near Patient Care Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129165
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Near Patient Care Diagnostic Market is projected to reach USD 32.46 Billion in 2026. It is expected to continue growing at a CAGR of 7.07%, reaching USD 48.71 Billion by 2032.

Near-Patient Care Diagnostics: Executive Overview

Near-patient care diagnostics bring testing closer to the patient, enabling clinical decisions in emergency departments, primary-care settings, pharmacies, ambulances, remote clinics, and homes. The field includes portable analyzers, rapid tests, connected devices, and workflow software that support faster assessment while reducing dependence on centralized laboratories. Adoption is shaped by analytical performance, regulatory requirements, reimbursement, ease of use, connectivity, and the ability to integrate results into clinical records.

Care Delivery Is Shifting Toward Decentralized Testing

Healthcare systems are increasingly prioritizing timely diagnosis, shorter care pathways, and access outside major hospitals. This is encouraging deployment of compact instruments, cartridge-based testing, multiplex assays, and digitally connected workflows. The most durable opportunities arise where near-patient testing addresses a defined clinical bottleneck, such as triage, infectious-disease decisions, chronic-disease monitoring, or urgent treatment selection. Implementation still depends on operator training, quality control, sample handling, procurement discipline, and interoperability with laboratory and hospital systems.

Artificial Intelligence Strengthens Interpretation and Workflow Coordination

Artificial intelligence is extending the value of near-patient diagnostics through image interpretation, anomaly detection, quality checks, clinical decision support, and predictive workflow management. Its practical impact is greatest when algorithms are embedded in validated devices or software and paired with clear escalation rules. Leaders should distinguish assistive tools from autonomous diagnosis, verify performance across patient populations, monitor model drift, and maintain human oversight. Secure data governance, explainability, cybersecurity, and regulatory alignment remain essential as diagnostic systems become more connected.

Regional Conditions Shape Adoption and Implementation

North America generally benefits from advanced clinical infrastructure, established digital-health ecosystems, and strong demand for rapid testing, although reimbursement and regulatory evidence requirements influence deployment. Latin America presents opportunities linked to primary-care access, decentralized services, and infectious-disease management, with affordability, distribution, and workforce capacity remaining important considerations. Europe emphasizes clinical quality, data protection, interoperability, and coordinated procurement across diverse health systems. The Middle East is investing in modern healthcare infrastructure and digitally enabled services, while implementation varies by national strategy and workforce availability. Africa’s needs are closely tied to infectious-disease surveillance, maternal and emergency care, rural access, supply-chain resilience, and device maintainability. Asia-Pacific combines highly sophisticated healthcare markets with large populations and uneven access, making localization, scalable training, and reliable connectivity central to successful deployment.

Economic and Security Alliances Influence Standards and Access

ASEAN markets are advancing decentralized care through cross-border health priorities, expanding private provision, and varied levels of infrastructure maturity. BRICS economies reflect diverse approaches to domestic manufacturing, public-health capacity, affordability, and regional supply resilience. The European Union places strong emphasis on harmonized regulation, data governance, interoperability, and evidence-based integration into care pathways. G7 systems tend to prioritize validation, cybersecurity, health-system efficiency, and integration with established laboratory networks. GCC countries are developing digitally enabled, centralized-to-decentralized care models supported by substantial infrastructure investment. NATO members may place additional emphasis on resilience, emergency preparedness, logistics, and diagnostics that can function in disrupted or austere environments.

Country Priorities Range from Access Expansion to High-Performance Integration

Australia is well suited to near-patient models that support rural and remote care, provided connectivity, logistics, and workforce support are addressed. Brazil and Mexico can benefit from decentralized testing that extends primary care and improves access beyond major urban centers. Canada’s geography creates a strong case for portable diagnostics alongside rigorous quality and reimbursement planning. China and India are important settings for scalable, cost-conscious platforms that can serve both advanced hospitals and underserved communities. France, Germany, Italy, Spain, and the United Kingdom are likely to emphasize evidence, interoperability, quality assurance, and integration with established public health systems. Japan and South Korea combine advanced technology adoption with expectations for reliability, workflow compatibility, and aging-population support. Russia’s deployment considerations include geographic reach, supply continuity, domestic capability, and access to trained operators. Across the United States, demand is supported by emergency, ambulatory, pharmacy, home, and decentralized-care applications, with compliance, reimbursement, and clinical integration remaining decisive.

Prioritize Validated Use Cases, Connected Workflows, and Operational Readiness

Industry leaders should begin with high-value clinical decisions where faster results measurably improve triage, treatment, monitoring, or referral. Select platforms using evidence for analytical accuracy, clinical utility, usability, and performance across relevant populations and settings. Build quality systems that cover training, calibration, controls, maintenance, lot management, and result review. Treat connectivity as a core requirement by integrating instruments with electronic records, laboratory information systems, dashboards, and public-health reporting where appropriate. Regional deployment plans should account for procurement, reimbursement, service networks, cybersecurity, language, power reliability, and supply continuity. AI-enabled features should be introduced through controlled validation, transparent governance, human review, and continuous post-deployment monitoring.

Methodology for a Reliable Near-Patient Diagnostics Assessment

The assessment should combine structured review of peer-reviewed research, regulatory materials, clinical guidelines, public-health publications, procurement information, and implementation evidence. Findings should be triangulated across diagnostic modality, care setting, clinical use case, operator type, connectivity requirement, and geography. Regional, group, and country comparisons should consider healthcare infrastructure, disease burden, laboratory access, reimbursement, regulatory maturity, workforce capability, digital readiness, and supply-chain conditions. Evidence quality should be evaluated for study design, population representativeness, comparator selection, operational context, and recency. Conclusions should be limited to documented adoption drivers, barriers, technology developments, and care-delivery implications rather than unsupported commercial extrapolation.

Near-Patient Diagnostics Will Be Defined by Clinical Utility and Trust

Near-patient care diagnostics are becoming an important component of more responsive and distributed healthcare. Their long-term value will depend less on portability alone than on dependable performance, appropriate clinical use, seamless workflow integration, and sustainable operating models. Organizations that pair validated technology with strong quality management, responsible AI practices, workforce enablement, and resilient service infrastructure will be better positioned to improve timely care across hospitals, communities, homes, and remote environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Near Patient Care Diagnostic Market, by Product Type
7.1. Introduction
7.2. Cardiac Biomarker Analyzers
7.3. Glucometers
7.4. Hematology Analyzers
7.5. Pregnancy Test Kits
7.6. Rapid Infectious Disease Tests
7.6.1. Gi Infection Tests
7.6.2. Respiratory Infection Tests
7.6.2.1. Covid-19 Tests
7.6.2.2. Influenza Tests
7.6.2.3. Rsv Tests
7.6.3. Sti Tests
8. Near Patient Care Diagnostic Market, by Technology
8.1. Introduction
8.2. Biosensors
8.3. Colorimetry
8.4. Immunoassays
8.5. Lateral Flow Assays
8.6. Molecular Diagnostics
9. Near Patient Care Diagnostic Market, by Application
9.1. Introduction
9.2. Cardiac Monitoring
9.3. Chronic Disease Monitoring
9.4. Hematology Screening
9.5. Infectious Disease Detection
9.6. Pregnancy Testing
10. Near Patient Care Diagnostic Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostics Laboratories
10.5. Home Care Users
10.6. Hospitals
11. Near Patient Care Diagnostic Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Hospital Supplies
11.5. Online Pharmacies
11.6. Retail Pharmacies
12. Near Patient Care Diagnostic Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Near Patient Care Diagnostic Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Near Patient Care Diagnostic Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Becton Dickinson and Company
16.3. bioMérieux SA
16.4. CTK Biotech, Inc.
16.5. Danaher Corporation
16.6. EKF Diagnostics Holdings plc
16.7. F. Hoffmann-La Roche AG
16.8. Hologic Inc.
16.9. LumiraDx Ltd.
16.10. Mesa Laboratories, Inc.
16.11. Nova Diagnostics
16.12. Ortho Clinical Diagnostics
16.13. Quidel Corporation
16.14. Siemens AG
16.15. Siemens Healthineers AG
16.16. Sysmex Corporation
16.17. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Near Patient Care Diagnostic Market, Years Considered for the Study
FIGURE 2. Global Near Patient Care Diagnostic Market, Research Design
FIGURE 3. Global Near Patient Care Diagnostic Market, Research Framework
FIGURE 4. Global Near Patient Care Diagnostic Market, Data Triangulation
FIGURE 5. Global Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Near Patient Care Diagnostic Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Near Patient Care Diagnostic Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Near Patient Care Diagnostic Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Near Patient Care Diagnostic Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Near Patient Care Diagnostic Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Near Patient Care Diagnostic Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Near Patient Care Diagnostic Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Near Patient Care Diagnostic Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Near Patient Care Diagnostic Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Near Patient Care Diagnostic Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Near Patient Care Diagnostic Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Near Patient Care Diagnostic Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Near Patient Care Diagnostic Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Near Patient Care Diagnostic Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Near Patient Care Diagnostic Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Near Patient Care Diagnostic Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Near Patient Care Diagnostic Market Segmentation & Coverage
TABLE 2. Global Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 3. Global Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Cardiac Biomarker Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cardiac Biomarker Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cardiac Biomarker Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Glucometers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Glucometers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Glucometers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hematology Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hematology Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hematology Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pregnancy Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pregnancy Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pregnancy Test Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Rapid Infectious Disease Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Rapid Infectious Disease Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Rapid Infectious Disease Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gi Infection Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Gi Infection Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Gi Infection Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Respiratory Infection Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Respiratory Infection Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Respiratory Infection Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Covid-19 Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Covid-19 Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Covid-19 Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Influenza Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Influenza Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Influenza Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Rsv Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Rsv Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Rsv Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Sti Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Sti Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Sti Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global Biosensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Biosensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Biosensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Colorimetry Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Colorimetry Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Colorimetry Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lateral Flow Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lateral Flow Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lateral Flow Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Cardiac Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiac Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiac Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Chronic Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Chronic Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Chronic Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Hematology Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Hematology Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Hematology Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Infectious Disease Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Infectious Disease Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Infectious Disease Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pregnancy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pregnancy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pregnancy Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Diagnostics Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Diagnostics Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Diagnostics Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Home Care Users Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Home Care Users Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Home Care Users Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Hospital Supplies Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Hospital Supplies Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Hospital Supplies Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. North America Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. North America Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. North America Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 113. North America Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 114. North America Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 115. North America Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. North America Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. North America Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Latin America Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Latin America Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. Latin America Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 121. Latin America Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 122. Latin America Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. Latin America Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. Latin America Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Latin America Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. Europe Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Europe Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Europe Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 129. Europe Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 130. Europe Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 131. Europe Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Europe Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Europe Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Middle East Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Middle East Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Middle East Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 137. Middle East Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 138. Middle East Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. Middle East Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. Middle East Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Middle East Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Africa Near Patient Care Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Africa Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. Africa Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 145. Africa Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 146. Africa Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. Africa Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Africa Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Africa Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Global Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. ASEAN Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. ASEAN Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. ASEAN Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 154. ASEAN Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 155. ASEAN Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. ASEAN Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. ASEAN Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. ASEAN Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. GCC Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. GCC Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 162. GCC Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 163. GCC Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. GCC Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. GCC Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. GCC Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. European Union Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. European Union Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. European Union Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 170. European Union Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 171. European Union Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. European Union Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. European Union Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. European Union Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. BRICS Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. BRICS Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. BRICS Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 178. BRICS Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 179. BRICS Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. BRICS Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. BRICS Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. BRICS Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. G7 Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. G7 Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. G7 Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 186. G7 Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 187. G7 Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. G7 Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. G7 Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. G7 Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. NATO Near Patient Care Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. NATO Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. NATO Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 194. NATO Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 195. NATO Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. NATO Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. NATO Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. NATO Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Global Near Patient Care Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 200. United States Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 201. United States Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. United States Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 203. United States Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 204. United States Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. United States Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. United States Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. United States Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Canada Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 209. Canada Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. Canada Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 211. Canada Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 212. Canada Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. Canada Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Canada Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Canada Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Mexico Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 217. Mexico Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Mexico Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 219. Mexico Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 220. Mexico Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Mexico Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Mexico Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Mexico Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Brazil Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 225. Brazil Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Brazil Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 227. Brazil Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 228. Brazil Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. Brazil Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Brazil Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Brazil Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. United Kingdom Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 233. United Kingdom Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. United Kingdom Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 235. United Kingdom Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 236. United Kingdom Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. United Kingdom Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. United Kingdom Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. United Kingdom Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Germany Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 241. Germany Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. Germany Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 243. Germany Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 244. Germany Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. Germany Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Germany Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Germany Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. France Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 249. France Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. France Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 251. France Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 252. France Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. France Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. France Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. France Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Russia Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 257. Russia Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Russia Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 259. Russia Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 260. Russia Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 261. Russia Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Russia Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Russia Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Italy Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 265. Italy Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Italy Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 267. Italy Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 268. Italy Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Italy Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Italy Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Italy Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. Spain Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 273. Spain Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. Spain Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 275. Spain Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 276. Spain Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Spain Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Spain Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Spain Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. China Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 281. China Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. China Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 283. China Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 284. China Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 285. China Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. China Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. China Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. India Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 289. India Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. India Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 291. India Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 292. India Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. India Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. India Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. India Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 296. Japan Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 297. Japan Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. Japan Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 299. Japan Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 300. Japan Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 301. Japan Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. Japan Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Japan Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Australia Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 305. Australia Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. Australia Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 307. Australia Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 308. Australia Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. Australia Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. Australia Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Australia Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. South Korea Near Patient Care Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 313. South Korea Near Patient Care Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. South Korea Near Patient Care Diagnostic Market Size, by Rapid Infectious Disease Tests, 2017-2032 (USD Million)
TABLE 315. South Korea Near Patient Care Diagnostic Market Size, by Respiratory Infection Tests, 2017-2032 (USD Million)
TABLE 316. South Korea Near Patient Care Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 317. South Korea Near Patient Care Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. South Korea Near Patient Care Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. South Korea Near Patient Care Diagnostic Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. Global Near Patient Care Diagnostic Market Share, by Key Player, 2025
TABLE 321. Global Near Patient Care Diagnostic Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • bioMérieux SA
  • CTK Biotech, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • LumiraDx Ltd.
  • Mesa Laboratories, Inc.
  • Nova Diagnostics
  • Ortho Clinical Diagnostics
  • Quidel Corporation
  • Siemens AG
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Diagnostic Testing Market Report and Forecast 2025-2034 - Product Image

Diagnostic Testing Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
United States Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

United States Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Biological Age and Longevity Diagnostics Market Global Report 2026 - Product Image

Biological Age and Longevity Diagnostics Market Global Report 2026

  • Report
  • 250 Pages
  • Global
From
Bacterial Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bacterial Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Respiratory Infection Diagnostics Market - Global Forecast 2026-2032 - Product Image

Respiratory Infection Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.